Big investors keener on cannabis MSOs as rescheduling looms, survey shows
Institutional investors are increasingly bullish on U.S. cannabis multistate operators, according to a new survey, which suggests marijuana…
News November 8Institutional investors are increasingly bullish on U.S. cannabis multistate operators, according to a new survey, which suggests marijuana…
News November 8From zealous drug warrior to out-of-touch elder statesman to the regulated marijuana industry’s savior apparent. President Joe Biden’s…
News November 7As the U.S. Drug Enforcement Administration weighs whether to revise marijuana to a Schedule 3 controlled substance, regulated…
News October 17Two key Republican senators sponsoring cannabis banking reform are now pushing new legislation to thwart the Biden administration’s…
News September 22A new cannabis exchange traded fund (ETF) has been launched by Subversive Capital Advisor based on the potential…
News September 20The U.S. Drug Enforcement Administration will “likely” reschedule marijuana, following federal health regulators’ Aug. 29 recommendation, according to…
News September 15Rescheduling marijuana is positive news in an industry desperate for good news. But make no mistake, it is…
News September 15At least five states with medical marijuana programs have shared key data - including the products patients are…
News July 13Rescheduling cannabis from Schedule 1 to Schedule 2 would be the worst-case scenario for Main Street marijuana businesses.
News May 26